2,019
Views
40
CrossRef citations to date
0
Altmetric
Research Paper

M-CSF cooperating with NFκB induces macrophage transformation from M1 to M2 by upregulating c-Jun

, , , , , , , & show all
Pages 99-107 | Received 14 Jun 2013, Accepted 06 Oct 2013, Published online: 22 Oct 2013

References

  • Kavitha CV, Deep G, Gangar SC, Jain AK, Agarwal C, Agarwal R. Silibinin inhibits prostate cancer cells- and RANKL-induced osteoclastogenesis by targeting NFATc1, NF-κB, and AP-1 Activation in RAW264.7 cells. Mol Carcinog 2012; http://dx.doi.org/10.1002/mc.21959; PMID: 23115104
  • Stanley ER, Guilbert LJ, Tushinski RJ, Bartelmez SH. CSF-1--a mononuclear phagocyte lineage-specific hemopoietic growth factor. J Cell Biochem 1983; 21:151 - 9; http://dx.doi.org/10.1002/jcb.240210206; PMID: 6309875
  • Vesely PW, Staber PB, Hoefler G, Kenner L. Translational regulation mechanisms of AP-1 proteins. Mutat Res 2009; 682:7 - 12; http://dx.doi.org/10.1016/j.mrrev.2009.01.001; PMID: 19167516
  • Edwards DR. Cell signalling and the control of gene transcription. Trends Pharmacol Sci 1994; 15:239 - 44; http://dx.doi.org/10.1016/0165-6147(94)90318-2; PMID: 7940986
  • Wang Q, Ni H, Lan L, Wei X, Xiang R, Wang Y. Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2d macrophages. Cell Res 2010; 20:701 - 12; http://dx.doi.org/10.1038/cr.2010.52; PMID: 20386569
  • Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001; 193:727 - 40; http://dx.doi.org/10.1084/jem.193.6.727; PMID: 11257139
  • Chambers SK. Role of CSF-1 in progression of epithelial ovarian cancer. Future Oncol 2009; 5:1429 - 40; http://dx.doi.org/10.2217/fon.09.103; PMID: 19903070
  • Kacinski BM. CSF-1 and its receptor in ovarian, endometrial and breast cancer. Ann Med 1995; 27:79 - 85; http://dx.doi.org/10.3109/07853899509031941; PMID: 7742005
  • Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, Kastelein R, Kolk A, de Waal-Malefyt R, Ottenhoff TH. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci U S A 2004; 101:4560 - 5; http://dx.doi.org/10.1073/pnas.0400983101; PMID: 15070757
  • Morandi A, Barbetti V, Riverso M, Dello Sbarba P, Rovida E. The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines. PLoS One 2011; 6:e27450; http://dx.doi.org/10.1371/journal.pone.0027450; PMID: 22096574
  • Makarov SS. NF-kappaB as a therapeutic target in chronic inflammation: recent advances. Mol Med Today 2000; 6:441 - 8; http://dx.doi.org/10.1016/S1357-4310(00)01814-1; PMID: 11074370
  • Saccani A, Schioppa T, Porta C, Biswas SK, Nebuloni M, Vago L, Bottazzi B, Colombo MP, Mantovani A, Sica A. p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res 2006; 66:11432 - 40; http://dx.doi.org/10.1158/0008-5472.CAN-06-1867; PMID: 17145890
  • Kovács KJ, Sawchenko PE. Sequence of stress-induced alterations in indices of synaptic and transcriptional activation in parvocellular neurosecretory neurons. J Neurosci 1996; 16:262 - 73; PMID: 8613792
  • Larsen PJ, Mikkelsen JD. Functional identification of central afferent projections conveying information of acute “stress” to the hypothalamic paraventricular nucleus. J Neurosci 1995; 15:2609 - 27; PMID: 7536817
  • Duluc D, Delneste Y, Tan F, Moles MP, Grimaud L, Lenoir J, Preisser L, Anegon I, Catala L, Ifrah N, et al. Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. Blood 2007; 110:4319 - 30; http://dx.doi.org/10.1182/blood-2007-02-072587; PMID: 17848619
  • Minden A, Lin A, Claret FX, Abo A, Karin M. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 1995; 81:1147 - 57; http://dx.doi.org/10.1016/S0092-8674(05)80019-4; PMID: 7600582
  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646 - 74; http://dx.doi.org/10.1016/j.cell.2011.02.013; PMID: 21376230
  • Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140:883 - 99; http://dx.doi.org/10.1016/j.cell.2010.01.025; PMID: 20303878
  • Coussens LM, Werb Z. Inflammatory cells and cancer: think different!. J Exp Med 2001; 193:F23 - 6; http://dx.doi.org/10.1084/jem.193.6.F23; PMID: 11257144
  • Wang LJ, Zhou X, Wang W, Tang F, Qi CL, Yang X, Wu S, Lin YQ, Wang JT, Geng JG. Andrographolide inhibits oral squamous cell carcinogenesis through NF-κB inactivation. J Dent Res 2011; 90:1246 - 52; http://dx.doi.org/10.1177/0022034511418341; PMID: 21841043
  • Li YD, Ye BQ, Zheng SX, Wang JT, Wang JG, Chen M, Liu JG, Pei XH, Wang LJ, Lin ZX, et al. NF-kappaB transcription factor p50 critically regulates tissue factor in deep vein thrombosis. J Biol Chem 2009; 284:4473 - 83; http://dx.doi.org/10.1074/jbc.M806010200; PMID: 19095643
  • Ziegler-Heitbrock HW, Petersmann I, Frankenberger M. p50 (NF-kappa B1) is upregulated in LPS tolerant P388D1 murine macrophages. Immunobiology 1997; 198:73 - 80; http://dx.doi.org/10.1016/S0171-2985(97)80028-9; PMID: 9442379
  • Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003; 3:133 - 46; http://dx.doi.org/10.1038/nri1001; PMID: 12563297
  • Bohuslav J, Kravchenko VV, Parry GC, Erlich JH, Gerondakis S, Mackman N, Ulevitch RJ. Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. J Clin Invest 1998; 102:1645 - 52; http://dx.doi.org/10.1172/JCI3877; PMID: 9802878
  • Liu J, Beller D. Aberrant production of IL-12 by macrophages from several autoimmune-prone mouse strains is characterized by intrinsic and unique patterns of NF-kappa B expression and binding to the IL-12 p40 promoter. J Immunol 2002; 169:581 - 6; PMID: 12077291
  • Kanarek N, Ben-Neriah Y. Regulation of NF-κB by ubiquitination and degradation of the IκBs. Immunol Rev 2012; 246:77 - 94; http://dx.doi.org/10.1111/j.1600-065X.2012.01098.x; PMID: 22435548
  • Tanaka H, Fujita N, Tsuruo T. 3-Phosphoinositide-dependent protein kinase-1-mediated IkappaB kinase beta (IkkB) phosphorylation activates NF-kappaB signaling. J Biol Chem 2005; 280:40965 - 73; http://dx.doi.org/10.1074/jbc.M506235200; PMID: 16207722
  • Suh SJ, Kwak CH, Chung TW, Park SJ, Cheeeei M, Park SS, Seo CS, Son JK, Chang YC, Park YG, et al. Pimaric acid from Aralia cordata has an inhibitory effect on TNF-α-induced MMP-9 production and HASMC migration via down-regulated NF-κB and AP-1. Chem Biol Interact 2012; 199:112 - 9; http://dx.doi.org/10.1016/j.cbi.2012.06.003; PMID: 22705379
  • Lu Y, Suh SJ, Li X, Liang JL, Chi M, Hwangbo K, Kwon O, Chung TW, Kwak CH, Kwon KM, et al. Citreorosein inhibits production of proinflammatory cytokines by blocking mitogen activated protein kinases, nuclear factor-κB and activator protein-1 activation in mouse bone marrow-derived mast cells. Biol Pharm Bull 2012; 35:938 - 45; http://dx.doi.org/10.1248/bpb.35.938; PMID: 22687535

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.